News
All news from Vismederi Holding
Students from Kent State University (USA) visiting VisMederi Group
This morning at the Auditorium of the Toscana Life Sciences Foundation, the company ETHS Srl, part of the VisMederi Group, received a visit from the students of Kent State University (USA) taking part in the "Florence Health Institute" (FHI) Program, thanks to an...
The VisMederi Group keeps growing: turnovers of over 25 million Euros
The VisMederi Group keeps growing: its companies closed 2021 budgets with turnovers of over 25 million Euros. This represents an important result, closing a year still deeply affected by Covid-19 and vaccinations. Other significant numbers: 20% trading profit, 37%...
Accredia accreditation ISO 17025: VisMederi Life Sciences joined Exposanità
Important new developments for VisMederi Life Sciences. One of the exclusive tests promoted, related to the evaluation of the anti-SARS-CoV-2 activity of appropriately treated fabrics and surfaces, has now also obtained Accredia accreditation, according to ISO...
MRna vaccines, VisMederi srl takes part into research on healthcare workers
VisMederi Srl took part into research on antibody and cellular response induced by mRna vaccine against Covid-19. This trial involved a group of 352 healthcare workers, 180 days after the second shot of Pfizer-Biontech mRna vaccine. VisMederi founder and CSO...
VisMederi Textyle becomes the reference center for Peta association
VisMederi Textyle, the VisMederi group company dealing with Quality Control on textile materials, becomes the reference centre for the international non-profit association Peta “People for the Ethical Treatment of Animals”. “Our task – CEO Giovanni Micheli says –...
VisMederi: a new anti Covid vaccine made in Italy
A new candidate vaccine against Covid-19 to be administered without a needle. It is called LeCoVax2 and, both for its mechanism of action and for its characteristics, it represents an absolute novelty in the battle against Sars-CoV-2. VisMederi and University of...
